A Haverhill landmark has been renamed as the Genzyme towers have had their signage changed to Sanofi.
The branding change at one of Haverhill’s largest employers, in Rookwood Way, marks the plant’s final steps in its integration with global pharmaceutical company Sanofi.
The company’s acquisition of Genzyme brings sustainability and potential future growth of the site.
In 2011 the pharmaceutical firm then known as Sanofi-Aventis acquired US-based Genzyme.
Over the past two years Genzyme’s site in Haverhill has gradually integrated with Sanofi’s pharma injectables operations unit.
Matthieu Cortinovis, head of the site said: “We remain as Genzyme Ltd but adoption of Sanofi’s ‘Bird of hope’ logo in our branding recognises our shared vision of the future to develop breakthrough and transformative treatments for patients worldwide.”
The staff will continue to support local healthcare, science, education and the environmental projects, including being the primary sponsor for the inaugural HaverHalf and Haver10 races on May 11.
Carole Rayner, from the company, said: “We will continue to develop our strong links with the Haverhill community, with popular projects such as work experience and school tours programmes.”
This year, the 350 staff at Sanofi at Haverhill will fund raise for St Nicholas Hospice Care as the palliative care home celebrates its 30-year anniversary.
Employees will also continue to support the Teenage Cancer Trust, Sanofi’s chosen charity partner for 2014.
For all the latest news see Thursday’s (February 6) Echo.